TradingView
RocketTickers
23 kwi 2021 19:02

FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Ca Long

NASDAQ:ANAB60
AnaptysBio, Inc.NASDAQ

Opis

⋅
ANAB: AnaptysBio, Inc.
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
Beyond Technical Analysis
Więcej